Differentiation of malignant and benign solitary thyroid nodules using 30- and 120-minute Tc-99m MIBI scans

Clinical Nuclear Medicine

Volumn 29, Issue 9, 2004, Pages 534-537

  Sharma, Rajnish ^a   Mondal, Anupam ^a   Shankar, L Ravi ^a   Sahoo, M ^a   Bhatnagar, Parul ^a   Sawroop, K ^a   Chopra, M K ^a   Kashyap, Ravi ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

120 30 minute radiouptake ratio (RUR); Tc 99m MIBI scan; Thyroid cancer

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; ASPIRATION CYTOLOGY; DIAGNOSTIC VALUE; FEMALE; GOITER; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THYROID ADENOMA; THYROID CYST; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; THYROID NODULE;

EID: 4243180373     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000135008.16779.0e     Document Type: Article

References (23)

1. Biles M, Albert T, Cote M, et al. Sestamibi parathyroid imaging. Semin Nucl Med. 1995;25:221.
2. Coakley A, Kettle A, Wells M, et al. Technetium 99mTc- sestamibi: a new agent for parathyroid imaging. Nucl Med Commun. 1989;10:791.
3. Briele B, Hotze A, Kropp J, et al. A comparison of 201-T1 and 99mTc-MIBI in the follow up of differentiated carcinoma of thyroid. Nuklearmedizin. 1991;30:115.
4. Shinichi M, Kasagai K, Misaki T, et al. Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma. J Nucl Med. 1997;38:352.
5. Aktolun C, Bayhan H, Kir M. Clinical experiences with 99mTc-MIBI imaging in-patients with malignant tumors. Preliminary results and comparison with 201-T1. Clin Nucl Med. 1992;17:171.
6. Hoefnagel C, Delprat C, Marcuse H, et al. Role of thallium-201 total body scintigraphy in follows up of thyroid cancer. J Nucl Med. 1986; 12:1854.
7. Harada T, Ito Y, Shimaoka K, et al. clinical evaluation of thallium-201 chloride scan for thyroid nodule. Eur J Nucl Med. 1980;5:125.
8. Bhatnagar A, Mondal A, Sharma R, et al. Differentiation of malignant and degenerative bone lesions using dexamethasone interventional 3 and 24 hour bone scintigraphy. Eur J Nucl Med. 1994;21:609.
9. Hoefnagel C, Delprat C, Marcuse H, et al. Role of thallium-201 total body scintigraphy in follow up of thyroid cancer. J Nucl Med. 1986;12:1854.
10. Harada T, Ito Y, Shimaoka K, et al. Clinical evaluation of thallium-201 chloride scans for thyroid nodules. Eur J Nucl Med. 1980;5:125.
11. Piwnica Worms D, Chiu M, Kronauge J. Effect of mitochondrial and plasma membrane potentials on accumulation of MIBI technetium in cultured mouse fibroblasts. J Nucl Med. 1990;10:1646.
12. Sathekge MM, Mageza RB, Muthuphei MN, et al. Evaluation of thyroid nodules with technetium-99m-MIBI and technetium-99m pertechnetate. Head Neck. 2001;23:305.
13. Mezosi E, Bajnok L, Gyory F, et al. The role of Tc-99m-MIBI scintigraphy in the differential diagnosis of cold thyroid nodules. Eur J Nucl Med. 1999;26:798.
14. Plind P. Multitracer imaging of thyroid nodules: is there a role in the pre-operative assessment of nodular goiter? Eur J Nucl Med. 1999;26:795.
15. Foldes I, Levay A, Stotz G. Comparative scanning of thyroid nodules with 99mTc-pertechnetate and 99mTc- MIBI. Eur J Nucl Med. 1993; 20:330.
16. Sundram FXMack POP. Investigation of thyroid nodules using 99mTc-sestamibi. Ann Acad Med Singapore. 1993;22:560.
17. Wei JP, Burke GJ. Characterization of neoplastic potential of solitary thyroid lesions with 99mTc- pertechnetate and 99mTc-sestamibi scanning. Ann Surg Oncol. 1995;2:233.
18. Karayalcin U, Ciftci F, Boz A, et al. The value of 99mTc-tetrofosmin thyroid scintigraphy in-patients with nodular goiter. Ann Nucl Med. 1997;11:285.
19. Erdem S, Bashekim C, Kizilkaya C, et al. Clinical applications of 99mTc-tetrofosmin scintigraphy in-patients with cold thyroid nodules. Comparison with color Doppler sonography. Clin Nucl Med. 1997;22:76.
20. Kresnik E, Gallowitsch HJ, Mikosch P, et al. Evaluation of thyroid nodules using 99mTc-tetrofosmin dual phase scintigraphy. Eur J Nucl Med. 1997;24:716.
21. Guan S, Chu L, Hwang W, et al. The differential diagnosis of benign and malignant bony lesions in bone scanning.
22. Israel O, Front D, Frenkel A, et al. 24 hour/4 hour ratio of technetium 99m methylene diphosphonate uptake in-patients with bone metastasis and degenerative bone changes. J Nucl Med. 1985;26:237.
23. Kashyap R, Bhatnagar A, Mondal A, et al. 24/3-hour radio-uptake technique for differentiating degenerative and malignant bone lesions in bone scintigraphy. Australas Radiol. 1993;37:198.